$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice 원문보기

Lipids in health and disease, v.16, 2017년, pp.145 -   

Sun, Jing-Hui (College of Pharmacy, Beihua University, 3999 Binjiang East Road, Jilin, 132013 China) ,  Liu, Xu (College of Pharmacy, Beihua University, 3999 Binjiang East Road, Jilin, 132013 China) ,  Cong, Li-Xin (Second Treatment Area of Senile Disease, First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, 1478, Gongnong Road, Changchun, 130021 China) ,  Li, He (College of Pharmacy, Beihua University, 3999 Binjiang East Road, Jilin, 132013 China) ,  Zhang, Cheng-Yi (College of Pharmacy, Beihua University, 3999 Binjiang East Road, Jilin, 132013 China) ,  Chen, Jian-Guang (College of Pharmacy, Beihua University, 3999 Binjiang East Road, Jilin, 132013 China) ,  Wang, Chun-Mei (College of Pharmacy, Beihua University, 3999 Binjiang East Road, Jilin, 132013 China)

Abstract AI-Helper 아이콘AI-Helper

BackgroundSchisandra, a globally distributed plant, has been widely applied for the treatment of diseases such as hyperlipidemia, fatty liver and obesity in China. In the present work, a rapid resolution liquid chromatography coupled with quadruple-time-of-flight mass spectrometry (RRLC-Q-TOF-MS)-ba...

주제어

참고문헌 (64)

  1. 1. O'Keefe JH Bell DS Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor Am J Cardiol 2007 100 5 899 904 10.1016/j.amjcard.2007.03.107 17719342 

  2. 2. Fazio S Linton MRF The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy Curr Atheroscler Rep 2004 6 2 148 157 10.1007/s11883-004-0104-8 15023300 

  3. 3. Farnier M Davignon J Current and future treatment of hyperlipidemia: the role of statins Am J Cardiol 1998 82 4 3J 10J 10.1016/S0002-9149(98)00423-8 9737640 

  4. 4. Saydah SH Fradkin J Cowie CC Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 2004 291 3 335 342 10.1001/jama.291.3.335 14734596 

  5. 5. Jr IW Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review South Med J 2006 99 3 257 273 10.1097/01.smj.0000208120.73327.db 16553100 

  6. 6. Asbach P Paetsch I Stawowy P Sander B Fleck E Statin-associated focal myositis Int J Cardiology 2009 133 1 e33 e34 10.1016/j.ijcard.2007.08.109 

  7. 7. Wu J Song Y Li H Chen J Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report Eur J Clin Pharmacol 2009 65 12 1169 1174 10.1007/s00228-009-0723-7 19756555 

  8. 8. Chiu PY Mak DH Poon MK Ko KM In vivo antioxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone-containing extract of Polygonum root in comparison with schisandrin B and emodin Planta Med 2002 68 11 951 956 10.1055/s-2002-35661 12451481 

  9. 9. Panossian A Wikman G Pharmacology of Schisandra Chinensis bail.: an overview of Russian research and uses in medicine J Ethnopharmacol 2008 118 2 183 212 10.1016/j.jep.2008.04.020 18515024 

  10. 10. Xie W Du L Diabetes is an inflammatory disease: evidence from traditional Chinese medicines Diabetes Obes Metab 2011 13 4 289 301 10.1111/j.1463-1326.2010.01336.x 21205111 

  11. 11. Sun N Pan SY Zhang Y Wang XY Zhu PL Chu ZS Yu ZL Zhou SF Ko KM Dietary pulp from Fructus Schisandra Chinensis supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet Lipids Health Dis 2014 13 1 46 10.1186/1476-511X-13-46 24621253 

  12. 12. Wat E Ng CF Wong EC Koon CM Lau CP Cheung DW Fung KP Lau CB Leung PC The hepatoprotective effect of the combination use of Fructus Schisandrae with statin-a preclinical evaluation J Ethnopharmacol 2015 178 104 114 10.1016/j.jep.2015.12.004 26666731 

  13. 13. Chu ZS Yu ZL Pan SY Jia ZH Wang XY Zhang Y Zhu PL Wang XJ Ko KM A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice Lipids Health Dis 2015 14 1 1 12 10.1186/s12944-015-0097-z 25575766 

  14. 14. Ellis DI Dunn WB Griffin JL Allwood JW Goodacre R Metabolic fingerprinting as a diagnostic tool Pharmacogenomics 2007 8 9 1243 1266 10.2217/14622416.8.9.1243 17924839 

  15. 15. Legg K Metabolomics: gaining insight into pain Nat Rev Drug Discov 2012 11 3 188 189 10.1038/nrd3685 22378263 

  16. 16. Nicholson JK Metabonomics in pharmaceutical R&D FEBS J 2007 274 5 1140 1151 10.1111/j.1742-4658.2007.05673.x 17298438 

  17. 17. Zhang Q Wang GJ A JY, ma B, Dua Y, Zhu L, Wu D. Metabonomic profiling of diet-induced hyperlipidaemia in a rat model Biomarkers 2009 15 3 205 216 10.3109/13547500903419049 

  18. 18. Martin JC Canlet C Delplanque B Agnani G Lairon D Gottardi G Bencharif K Gripois D Thaminy A Paris A 1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters Atherosclerosis 2009 206 1 127 133 10.1016/j.atherosclerosis.2009.01.040 19324361 

  19. 19. Zha WB A JY, Wang GJ, Yan B, Gu S, Zhu X, Hao H, Huang Q, sun J, Zhang Y, Cao B, Ren H. Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol Biomarkers 2009 14 6 372 380 10.1080/13547500903026401 19552617 

  20. 20. Gu Y Zhang Y Shi X Li X Hong J Chen J Gu W Lu X Xu G Ning G Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics Talanta 2010 81 3 766 772 10.1016/j.talanta.2010.01.015 20298851 

  21. 21. Liu F Gan PP Wu H Woo WS Ong ES Li SF A combination of metabolomics and metallomics studies of urine and serum from hypercholesterolaemic rats after berberine injection Anal Bioanal Chem 2012 403 3 847 856 10.1007/s00216-012-5923-9 22434276 

  22. 22. http://www.hmdb.ca /. Accessed 15 May 2016. 

  23. 23. http://www.lipidmaps.org /. Accessed 15 May 2016. 

  24. 24. http://www.genome.jp/kegg/ . Accessed 20 May 2016. 

  25. 25. Munshi RP Joshi SG Rane BN Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance, markers for coronary heart disease Indian J Pharmacol 2014 46 3 270 276 10.4103/0253-7613.132156 24987172 

  26. 26. Sun YJ Wang HP Liang YJ Yang L Li W Wu YJ An NMR-based metabonomic investigation of the subacute effects of melamine in rats J Proteome Res 2012 11 4 2544 2550 10.1021/pr2012329 22401608 

  27. 27. Kalhan SC Guo L Edmison J Dasarathy S McCullough AJ Hanson RW Millburn M Plasma metabolomic profile in nonalcoholic fatty liver disease Metabolism 2011 60 3 404 413 10.1016/j.metabol.2010.03.006 20423748 

  28. 28. Mallin K McCann K D'Aloisio A Freels S Piorkowski J Dimos J Persky V Cohort mortality study of capacitor manufacturing workers, 1944-2000 J Occup Environ Med 2004 46 6 565 576 10.1097/01.jom.0000128156.24767.12 15213519 

  29. 29. Barr J Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease Behav Ecol 2010 9 9 4501 4512 

  30. 30. Jiang CY Yang KM Yang L Miao ZX Wang YH Zhu HB A (1)H NMR-based Metabonomic investigation of time-related metabolic trajectories of the plasma, urine and liver extracts of Hyperlipidemic hamsters PLoS One 2012 8 6 10.1371/journal.pone.0066786 

  31. 31. Lopansri BK Anstey NM Stoddard GJ Mwaikambo ED Boutlis CS Tjitra E Maniboey H Hobbs MR Levesque MC Weinberg JB Granger DL Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications Infect Immun 2006 74 6 3355 3359 10.1128/IAI.02106-05 16714564 

  32. 32. Miao H Chen H Zhang X Yin L Chen DQ Cheng XL Bai X Wei F Urinary metabolomics on the biochemical profiles in diet-induced hyperlipidemia rat using Ultraperformance liquid chromatography coupled with Quadrupole time-of-flight SYNAPT high-definition mass spectrometry J Anal Methods Chem 2014 2014 11 184162 24757578 

  33. 33. Holecek M The BCAA-BCKA cycle: its relation to alanine and glutamine synthesis and protein balance Nutrition 2001 17 1 70 10.1016/S0899-9007(00)00483-4 11165898 

  34. 34. Doi M Yamaoka I Nakayama M Sugahara K Yoshizawa F Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis Am J Physiol Endocrinol Metab 2007 292 6 E1683 E1693 10.1152/ajpendo.00609.2006 17299083 

  35. 35. Lynch CJ Gern B Lloyd C Hutson SM Eicher R Vary TC Leucine in food mediates some of the postprandial rise in plasma leptin concentrations Am J Physiol Endocrinol Metab 2006 291 3 E621 E630 10.1152/ajpendo.00462.2005 16638821 

  36. 36. Wang M Wang F Wang YN Ma X Zhao M Zhao C Metabonomics study of the therapeutic mechanism of Gynostemma pentaphyllum and atorvastatin for hyperlipidemia in rats PLoS One 2013 8 11 10.1371/journal.pone.0078731 24223845 

  37. 37. Udenfriend S Wyngaarden JB Precursors of adrenal epinephrine and norepinephrine in vivo Biochim Biophys Acta 1956 20 1 48 52 10.1016/0006-3002(56)90261-X 13315348 

  38. 38. Dury A Effects of epinephrine on lipid partition and metabolism in the rabbit Circ Res 1957 5 1 47 53 10.1161/01.RES.5.1.47 13396962 

  39. 39. Zhang Q Wang GJ A JY, Wu D, Zhu LL, ma B, du Y. Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats Acta Pharmacol Sin 2009 30 12 1674 1687 10.1038/aps.2009.173 19960012 

  40. 40. Melis GC Ter WN Boelens PG van Leeuwen PA Glutamine: recent developments in research on the clinical significance of glutamine Curr Opin Clin Nutr Metab Care 2004 7 1 59 70 10.1097/00075197-200401000-00011 15090905 

  41. 41. Ahmed N Thornalley PJ Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence Biochem J 2002 364 Pt 1 15 24 10.1042/bj3640015 11988071 

  42. 42. Oörni K Pentikäinen MO Annila A Kovanen PT Oxidation of low density lipoprotein particles decreases their ability to bind to human aortic proteoglycans. Dependence on oxidative modification of the lysine residues J Biol Chem 1997 272 34 21303 21311 10.1074/jbc.272.34.21303 9261142 

  43. 43. Toborek M Kopieczna-Grzebieniak E Drózdz M Wieczorek M Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits Atherosclerosis 1995 115 2 217 224 10.1016/0021-9150(94)05516-L 7661880 

  44. 44. Bertram HC Larsen LB Chen X Jeppesen PB Impact of high-fat and high-carbohydrate diets on liver metabolism studied in a rat model with a systems biology approach J Agric Food Chem 2012 60 2 676 684 10.1021/jf203994k 22224854 

  45. 45. Lentz SR Mechanisms of homocysteine-induced atherothrombosis J Thromb Haemost 2005 3 8 1646 1654 10.1111/j.1538-7836.2005.01364.x 16102030 

  46. 46. Duarte IF Goodfellow BJ Barros A Jones JG Barosa C Diogo L Garcia P Gil AM Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high-resolution 1H NMR spectroscopy NMR Biomed 2007 20 4 401 412 10.1002/nbm.1073 17149801 

  47. 47. Yamamoto N Saitoh M Moriuchi A Nomura M Okuyama H Effect of dietary alpha-linolenate/linoleate balance on brain lipid compositions and learning ability of rats J Lipid Res 1987 28 2 144 151 2883248 

  48. 48. Wijendran V Hayes KC Dietary n-6 and n-3 fatty acid balance and cardiovascular health Annu Rev Nutr 2004 24 24 597 615 10.1146/annurev.nutr.24.012003.132106 15189133 

  49. 49. Russo GL Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention Biochem Pharmacol 2009 77 6 937 946 10.1016/j.bcp.2008.10.020 19022225 

  50. 50. Das UN Essential fatty acids: biochemistry, physiology and pathology Biotechnol J 2006 1 4 420 439 10.1002/biot.200600012 16892270 

  51. 51. Daemen S Kutmon M Evelo CT A pathway approach to investigate the function and regulation of SREBPs Genes Nutr 2013 8 3 289 300 10.1007/s12263-013-0342-x 23516131 

  52. 52. Horton JD Goldstein JL Brown MS SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver J Clin Invest 2002 109 9 1125 1131 10.1172/JCI0215593 11994399 

  53. 53. Foufelle F Ferré P New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c Biochem J 2002 366 Pt 2 377 391 10.1042/bj20020430 12061893 

  54. 54. Horton JD Shah NA Warrington JA Anderson NN Park SW Brown MS Goldstein JL Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes Proc Natl Acad Sci U S A 2003 100 21 12027 12032 10.1073/pnas.1534923100 14512514 

  55. 55. Morgan K Uyuni A Nandgiri G Mao L Castaneda L Kathirvel E French SW Morgan TR Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease Eur J Gastroenterol Hepatol 2008 20 9 843 854 10.1097/MEG.0b013e3282f9b203 18794597 

  56. 56. Min HK Kapoor A Fuchs M Mirshahi F Zhou H Maher J Kellum J Warnick R Contos MJ Sanyal AJ Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease Cell Metab 2012 15 5 665 674 10.1016/j.cmet.2012.04.004 22560219 

  57. 57. Repa JJ Liang G Ou J Bashmakov Y Lobaccaro JM Shimomura I Shan B Brown MS Goldstein JL Mangelsdorf DJ Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors LXRalpha and LXRbeta Genes Dev 2000 14 22 2819 2830 10.1101/gad.844900 11090130 

  58. 58. Lima-Cabello E García-Mediavilla MV Miquilena-Colina ME Vargas-Castrillón J Lozano-Rodríguez T Fernández-Bermejo M Olcoz JL González-Gallego J García-Monzón C Sánchez-Campos S Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C Clin Sci (Lond) 2011 120 6 239 250 10.1042/CS20100387 20929443 

  59. 59. Tilg H Moschen AR Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology 2010 52 5 1836 1846 10.1002/hep.24001 21038418 

  60. 60. Puri P Baillie RA Wiest MM Mirshahi F Choudhury J Cheung O Sargeant C Contos MJ Sanyal AJ A lipidomic analysis of nonalcoholic fatty liver disease Hepatology 2007 46 4 1081 1090 10.1002/hep.21763 17654743 

  61. 61. Caballero F Fernández A De Lacy AM Fernández-Checa JC Caballería J García-Ruiz C Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH J Hepatol 2009 50 4 789 796 10.1016/j.jhep.2008.12.016 19231010 

  62. 62. Rooyen DMV Farrell GC SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH J Gastroenterol Hepatol 2011 26 5 789 792 10.1111/j.1440-1746.2011.06704.x 21488942 

  63. 63. Ahmed MH Byrne CD Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD) Drug Discov Today 2007 12 17 740 747 10.1016/j.drudis.2007.07.009 17826687 

  64. 64. Musso G Gambino R Cassader M Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis Prog Lipid Res 2013 52 1 175 191 10.1016/j.plipres.2012.11.002 23206728 

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로